Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
| (FY)Sep 30, 2025 | (Q6)Mar 31, 2025 | (FY)Sep 30, 2024 | (Q6)Mar 31, 2024 | (FY)Sep 30, 2023 | (Q6)Mar 31, 2023 | (FY)Sep 30, 2022 | (Q6)Mar 31, 2022 | (FY)Sep 30, 2021 | (Q6)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -92.32%-12.02M | ---- | 19.03%-6.25M | ---- | -53.44%-7.72M | ---- | -178.16%-5.03M | ---- | -116.06%-1.81M | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 38.03%-1.75M | ---- | -100.28%-2.82M | ---- | -921.74%-1.41M | ---- | 22.47%-138K | ---- | 75.72%-178K | ---- |
| Interest expense - adjustment | 98.30%817K | ---- | -50.36%412K | ---- | -15.22%830K | ---- | 59.19%979K | ---- | -47.61%615K | ---- |
| Attributable subsidiary (profit) loss | --169K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Impairment and provisions: | 1,953.59%4.39M | ---- | -106.02%-237K | ---- | --3.94M | ---- | ---- | ---- | -29.48%2.56M | ---- |
| -Impairment of trade receivables (reversal) | 91.55%-257K | ---- | -177.29%-3.04M | ---- | --3.94M | ---- | ---- | ---- | 24.31%2.53M | ---- |
| -Other impairments and provisions | 65.72%4.65M | ---- | --2.81M | ---- | ---- | ---- | ---- | ---- | -97.93%33K | ---- |
| Depreciation and amortization: | -49.57%4.45M | ---- | -6.88%8.83M | ---- | -9.82%9.48M | ---- | -18.90%10.51M | ---- | 3.65%12.97M | ---- |
| Special items | -147.99%-981K | ---- | 1,985.71%2.04M | ---- | --98K | ---- | ---- | ---- | -14,900.00%-888K | ---- |
| Operating profit before the change of operating capital | -349.52%-4.92M | ---- | -62.17%1.97M | ---- | -17.51%5.22M | ---- | -52.33%6.32M | ---- | -52.37%13.26M | ---- |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | -341.91%-16.46M | ---- | 241.92%6.8M | ---- | -416.58%-4.79M | ---- | 130.37%1.51M | ---- | -232.02%-4.99M | ---- |
| Accounts payable increase (decrease) | 327.86%1.42M | ---- | -155.45%-621K | ---- | 139.97%1.12M | ---- | -41.52%-2.8M | ---- | -163.50%-1.98M | ---- |
| prepayments (increase)decrease | ---- | ---- | ---- | ---- | -58.40%317K | ---- | 113.45%762K | ---- | --357K | ---- |
| Special items for working capital changes | 322.79%4.18M | ---- | -111.72%-1.88M | ---- | -125.06%-887K | ---- | 45.08%3.54M | ---- | 378.86%2.44M | ---- |
| Cash from business operations | -351.42%-15.78M | ---- | 545.02%6.28M | ---- | -89.58%973K | ---- | 2.65%9.34M | ---- | -73.14%9.1M | ---- |
| Other taxs | --166K | ---- | ---- | ---- | -133.12%-617K | ---- | 447.94%1.86M | ---- | 12.96%340K | ---- |
| Special items of business | ---- | -322.11%-9.4M | ---- | 536.54%4.23M | ---- | -66.43%665K | ---- | -7.13%1.98M | ---- | -75.07%2.13M |
| Net cash from operations | -348.77%-15.61M | -322.11%-9.4M | 1,662.92%6.28M | 536.54%4.23M | -96.82%356K | -66.43%665K | 18.69%11.2M | -7.13%1.98M | -72.38%9.44M | -75.07%2.13M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -41.36%1.58M | -28.03%1.11M | 108.89%2.7M | 243.21%1.54M | 836.96%1.29M | 716.36%449K | -22.47%138K | -50.89%55K | -75.72%178K | -69.57%112K |
| Loan receivable (increase) decrease | ---3.5M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Decrease in deposits (increase) | 82.22%31.64M | 60.95%31.64M | 500.72%17.36M | 170.79%19.66M | 90.30%-4.33M | --7.26M | ---44.67M | ---- | ---- | ---- |
| Purchase of fixed assets | ---1.6M | ---156K | ---- | ---- | ---174K | ---65K | ---- | ---- | -52.70%-452K | ---378K |
| Acquisition of subsidiaries | ---178K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash on investment | ---1.04M | ---1.07M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items in the investment business | ---2.61M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | 21.11%24.3M | 48.72%31.53M | 724.27%20.06M | 177.35%21.2M | 92.78%-3.21M | 13,796.36%7.64M | -16,151.82%-44.53M | 120.68%55K | -162.70%-274K | -172.28%-266K |
| Net cash before financing | -67.02%8.69M | -13.01%22.12M | 1,021.62%26.34M | 206.10%25.43M | 91.43%-2.86M | 308.06%8.31M | -463.79%-33.33M | 9.05%2.04M | -73.52%9.16M | -79.08%1.87M |
| Cash flow from financing activities | ||||||||||
| Interest paid - financing | -122.16%-802K | -19.77%-309K | 53.54%-361K | 44.99%-258K | 20.63%-777K | -16.96%-469K | -59.19%-979K | -3.62%-401K | 47.61%-615K | ---387K |
| Net cash from financing operations | 27.04%-6.81M | 26.53%-3.43M | 0.55%-9.34M | 0.68%-4.67M | -7.09%-9.39M | 15.40%-4.7M | 32.09%-8.77M | 13.95%-5.55M | -4.58%-12.91M | -10.35%-6.45M |
| Net Cash | -88.98%1.87M | -9.97%18.7M | 238.81%17M | 475.21%20.77M | 70.91%-12.25M | 202.64%3.61M | -1,022.91%-42.1M | 23.31%-3.52M | -116.84%-3.75M | -249.04%-4.59M |
| Begining period cash | 147.05%28.56M | 147.05%28.56M | -51.44%11.56M | -51.44%11.56M | -63.87%23.81M | -63.87%23.81M | -5.38%65.91M | -5.38%65.91M | 46.96%69.66M | 46.96%69.66M |
| Cash at the end | 6.56%30.44M | 46.19%47.26M | 147.05%28.56M | 17.90%32.33M | -51.44%11.56M | -56.05%27.42M | -63.87%23.81M | -4.12%62.39M | -5.38%65.91M | 28.91%65.07M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Daxin Liang Xuelian (Hong Kong) Certified Public Accountants Limited | -- | Daxin Liang Xuelian (Hong Kong) Certified Public Accountants Limited | -- | Daxin Liang Xuelian (Hong Kong) Certified Public Accountants Limited | -- | Pang Zhijun Accounting Firm | -- | Pang Zhijun Accounting Firm | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.